Prediction and Classification of Alzheimer’s Disease Based on Combined Features From Apolipoprotein-E Genotype, Cerebrospinal Fluid, MR, and FDG-PET Imaging Biomarkers
暂无分享,去创建一个
Yubraj Gupta | Goo-Rak Kwon | Ramesh Kumar Lama | Alzheimer's Disease Neuroimaging Initiative | Alzheimer's Disease Neuroimaging Initiative | G. Kwon | R. Lama | Yubraj Gupta
[1] Nick C Fox,et al. Biomarkers in dementia: clinical utility and new directions , 2014, Journal of Neurology, Neurosurgery & Psychiatry.
[2] Goo-Rak Kwon,et al. Alzheimer's Disease Diagnosis Based on Cortical and Subcortical Features , 2019, Journal of healthcare engineering.
[3] Silvia Conforto,et al. Automated Segmentation of Colorectal Tumor in 3D MRI Using 3D Multiscale Densely Connected Convolutional Neural Network , 2019, Journal of healthcare engineering.
[4] Caroline Hayward,et al. Cognitive ability at age 11 and 70 years, information processing speed, and APOE variation: the Lothian Birth Cohort 1936 study. , 2009, Psychology and aging.
[5] Zoran Rumboldt,et al. Apolipoprotein E and gray matter volume loss in patients with mild cognitive impairment and Alzheimer disease. , 2011, Radiology.
[6] Kaj Blennow,et al. Cerebrospinal fluid protein biomarkers for Alzheimer’s disease , 2004, NeuroRX.
[7] Kingshuk Roy Choudhury,et al. Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers. , 2013, Radiology.
[8] Brian B. Avants,et al. N4ITK: Improved N3 Bias Correction , 2010, IEEE Transactions on Medical Imaging.
[9] Jeonghwan Gwak,et al. Diagnosis of Alzheimer's Disease Based on Structural MRI Images Using a Regularized Extreme Learning Machine and PCA Features , 2017, Journal of healthcare engineering.
[10] S. Burnham,et al. Blood-based molecular biomarkers for Alzheimer’s disease , 2019, Molecular Brain.
[11] Seong-Whan Lee,et al. Hierarchical feature representation and multimodal fusion with deep learning for AD/MCI diagnosis , 2014, NeuroImage.
[12] K. Blennow,et al. Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer’s disease: a community based follow up study , 1998, Journal of neurology, neurosurgery, and psychiatry.
[13] Timo Grimmer,et al. Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer’s disease , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[14] H. Braak,et al. Evolution of Alzheimer's disease related cortical lesions. , 1998, Journal of neural transmission. Supplementum.
[15] Chunlan Yang,et al. Structural MRI-based detection of Alzheimer's disease using feature ranking and classification error , 2016, Comput. Methods Programs Biomed..
[16] A. Dale,et al. Combining MR Imaging, Positron-Emission Tomography, and CSF Biomarkers in the Diagnosis and Prognosis of Alzheimer Disease , 2010, American Journal of Neuroradiology.
[17] Rebecca M. E. Steketee,et al. Multiparametric computer-aided differential diagnosis of Alzheimer’s disease and frontotemporal dementia using structural and advanced MRI , 2016, European Radiology.
[18] Ronald C Petersen,et al. Is the apolipoprotein e genotype a biomarker for mild cognitive impairment? Findings from a nationally representative study. , 2011, Neuropsychology.
[19] Samuel Kadoury,et al. Classification of Alzheimer's and MCI Patients from Semantically Parcelled PET Images: A Comparison between AV45 and FDG-PET , 2018, Int. J. Biomed. Imaging.
[20] Goo-Rak Kwon,et al. Diagnosis of Alzheimer's Disease Using Dual-Tree Complex Wavelet Transform, PCA, and Feed-Forward Neural Network , 2017, Journal of healthcare engineering.
[21] Rui Li,et al. Multi-modal discriminative dictionary learning for Alzheimer's disease and mild cognitive impairment , 2017, Comput. Methods Programs Biomed..
[22] Karl J. Friston,et al. Voxel-Based Morphometry—The Methods , 2000, NeuroImage.
[23] Ghulam Muhammad,et al. Development of the Arabic Voice Pathology Database and Its Evaluation by Using Speech Features and Machine Learning Algorithms , 2017, Journal of healthcare engineering.
[24] Frédéric Jurie,et al. Randomized Clustering Forests for Image Classification , 2008, IEEE Transactions on Pattern Analysis and Machine Intelligence.
[25] Chih-Jen Lin,et al. LIBSVM: A library for support vector machines , 2011, TIST.
[26] Corinna Cortes,et al. Support-Vector Networks , 1995, Machine Learning.
[27] Marie Chupin,et al. Automatic classi fi cation of patients with Alzheimer ' s disease from structural MRI : A comparison of ten methods using the ADNI database , 2010 .
[28] N. Foster,et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease , 1997, Annals of neurology.
[29] Gavin Brown,et al. Ensemble Learning , 2010, Encyclopedia of Machine Learning and Data Mining.
[30] M. Gilardi,et al. Magnetic resonance imaging biomarkers for the early diagnosis of Alzheimer's disease: a machine learning approach , 2015, Front. Neurosci..
[31] J. Morris. The Clinical Dementia Rating (CDR) , 1993, Neurology.
[32] Jesse S. Jin,et al. Identification of Conversion from Mild Cognitive Impairment to Alzheimer's Disease Using Multivariate Predictors , 2011, PloS one.
[33] M. Greiner,et al. Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. , 2000, Preventive veterinary medicine.
[34] Bradford C. Dickerson,et al. Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau , 2013, Front. Aging Neurosci..
[35] Frederik Barkhof,et al. Application of Machine Learning to Arterial Spin Labeling in Mild Cognitive Impairment and Alzheimer Disease. , 2016, Radiology.
[36] Xiaoying Wu,et al. Structural and functional biomarkers of prodromal Alzheimer's disease: A high-dimensional pattern classification study , 2008, NeuroImage.
[37] Rogier A. Feis,et al. Single Subject Classification of Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia Using Anatomical, Diffusion Tensor, and Resting-State Functional Magnetic Resonance Imaging. , 2018, Journal of Alzheimer's disease : JAD.
[38] Yu Zhang,et al. The Human Brainnetome Atlas: A New Brain Atlas Based on Connectional Architecture , 2016, Cerebral cortex.
[39] Ninon Burgos,et al. Reproducible evaluation of classification methods in Alzheimer's disease: Framework and application to MRI and PET data , 2018, NeuroImage.
[40] M. Jorge Cardoso,et al. Accurate multimodal probabilistic prediction of conversion to Alzheimer's disease in patients with mild cognitive impairment☆ , 2013, NeuroImage: Clinical.
[41] K. Blennow,et al. Imaging and CSF Studies in the Preclinical Diagnosis of Alzheimer's Disease , 2007, Annals of the New York Academy of Sciences.
[42] X. Chen,et al. Random forests for genomic data analysis. , 2012, Genomics.
[43] L. Fratiglioni,et al. Role of genes and environments for explaining Alzheimer disease. , 2006, Archives of general psychiatry.
[44] Chunxiang Jiang,et al. Prediction and classification of Alzheimer disease based on quantification of MRI deformation , 2017, PloS one.
[45] Michael Wagner,et al. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia , 2017, Alzheimer's Research & Therapy.
[46] Daoqiang Zhang,et al. Domain Transfer Learning for MCI Conversion Prediction , 2012, MICCAI.
[47] T. J. Grabowski,et al. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease , 2008 .
[48] R. Elwood,et al. The Wechsler Memory Scale—Revised: Psychometric characteristics and clinical application , 1991, Neuropsychology Review.
[49] C. Jack,et al. MRI and CSF biomarkers in normal, MCI, and AD subjects , 2009, Neurology.
[50] Tijn M. Schouten,et al. Combining anatomical, diffusion, and resting state functional magnetic resonance imaging for individual classification of mild and moderate Alzheimer's disease , 2016, NeuroImage: Clinical.
[51] Hasan Demirel,et al. Classification of Alzheimer's disease and prediction of mild cognitive impairment-to-Alzheimer's conversion from structural magnetic resource imaging using feature ranking and a genetic algorithm , 2017, Comput. Biol. Medicine.
[52] S. Resnick,et al. Detection of prodromal Alzheimer's disease via pattern classification of magnetic resonance imaging , 2008, Neurobiology of Aging.
[53] Gaël Varoquaux,et al. Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..
[54] L. McEvoy,et al. Predicting MCI outcome with clinically available MRI and CSF biomarkers , 2011, Neurology.
[55] Keith A. Johnson,et al. A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers , 2016, Neurology.
[56] Pierre Geurts,et al. Extremely randomized trees , 2006, Machine Learning.
[57] Anoop Arunagiri,et al. CSF Biomarkers for Alzheimer's Disease Diagnosis , 2010, International journal of Alzheimer's disease.
[58] H. Gertz,et al. Alzheimer’s Disease — From Basic Research to Clinical Applications , 1998, Journal of Neural Transmission. Supplementa.
[59] C. Jack,et al. Alzheimer's Disease Neuroimaging Initiative , 2008 .
[60] Ana Madevska Bogdanova,et al. Probabilistic SVM outputs for pattern recognition using analytical geometry , 2004, Neurocomputing.
[61] C. Jack,et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease , 2018, Alzheimer's & Dementia.
[62] Christopher Rorden,et al. The first step for neuroimaging data analysis: DICOM to NIfTI conversion , 2016, Journal of Neuroscience Methods.
[63] J. Trojanowski,et al. Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification , 2011, Neurobiology of Aging.
[64] Daoqiang Zhang,et al. Multimodal classification of Alzheimer's disease and mild cognitive impairment , 2011, NeuroImage.
[65] C. Jack,et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.
[66] Heikki Huttunen,et al. Machine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects , 2015, NeuroImage.
[67] R. Dixon,et al. Executive function performance and change in aging is predicted by apolipoprotein E, intensified by catechol-O-methyltransferase and brain-derived neurotrophic factor, and moderated by age and lifestyle , 2017, Neurobiology of Aging.
[68] Xiaoke Hao,et al. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer’s Disease Spectrum , 2015, Molecular Neurobiology.
[69] C. DeCarli,et al. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. , 2007, Brain : a journal of neurology.
[70] H. Rusinek,et al. Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[71] John Q. Trojanowski,et al. Healthy brain aging: A meeting report from the Sylvan M. Cohen Annual Retreat of the University of Pennsylvania Institute on Aging , 2008, Alzheimer's & Dementia.
[72] R. Petersen,et al. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects , 2009, Annals of neurology.
[73] H. Braak,et al. Staging of alzheimer's disease-related neurofibrillary changes , 1995, Neurobiology of Aging.
[74] Sébastien Ourselin,et al. Fast free-form deformation using graphics processing units , 2010, Comput. Methods Programs Biomed..
[75] Li Yao,et al. Prediction of Mild Cognitive Impairment Conversion Using a Combination of Independent Component Analysis and the Cox Model , 2017, Front. Hum. Neurosci..
[76] A. Dale,et al. CSF Biomarkers in Prediction of Cerebral and Clinical Change in Mild Cognitive Impairment and Alzheimer's Disease , 2010, The Journal of Neuroscience.
[77] Stuart W. S. MacDonald,et al. APOE and COMT polymorphisms are complementary biomarkers of status, stability, and transitions in normal aging and early mild cognitive impairment , 2014, Front. Aging Neurosci..
[78] Martina Sattlecker,et al. Are blood-based protein biomarkers for Alzheimer's disease also involved in other brain disorders? A systematic review. , 2014, Journal of Alzheimer's disease : JAD.
[79] R. Buchert,et al. Multimodal prediction of conversion to Alzheimer's disease based on incomplete biomarkers∗ , 2015, Alzheimer's & dementia.
[80] J B Poline,et al. Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease. , 2007, Brain : a journal of neurology.
[81] Daoqiang Zhang,et al. Predicting Future Clinical Changes of MCI Patients Using Longitudinal and Multimodal Biomarkers , 2012, PloS one.